Hou MF - Search Results

1

Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation.

Lee HH, Wang YN, Yang WH, Xia W, Wei Y, Chan LC, Wang YH, Jiang Z, Xu S, Yao J, Qiu Y, Hsu YH, Hwang WL, Yan M, Cha JH, Hsu JL, Shen J, Ye Y, Wu X, Hou MF, Tseng LM, Wang SC, Pan MR, Yang CH, Wang YL, Yamaguchi H, Pang D, Hortobagyi GN, Yu D, Hung MC. Lee HH, et al. Among authors: hou mf. Nat Commun. 2021 May 13;12(1):2788. doi: 10.1038/s41467-021-23075-2. Nat Commun. 2021. PMID: 33986289 Free PMC article.

2

[Secretory carcinoma of the breast--a case report].

Hou MF, Chai CY, Wuu JR, Shen YY, Lin HJ, Huang TJ. Hou MF, et al. Gaoxiong Yi Xue Ke Xue Za Zhi. 1995 Sep;11(9):546-51. Gaoxiong Yi Xue Ke Xue Za Zhi. 1995. PMID: 7474039 Chinese.

3

AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model.

Chen IF, Ou-Yang F, Hung JY, Liu JC, Wang H, Wang SC, Hou MF, Hortobagyi GN, Hung MC. Chen IF, et al. Among authors: hou mf. Mol Cancer Ther. 2006 Jan;5(1):1-7. doi: 10.1158/1535-7163.MCT-05-0310. Mol Cancer Ther. 2006. PMID: 16432157

4

Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.

Pan MR, Hou MF, Chang HC, Hung WC. Pan MR, et al. Among authors: hou mf. J Biol Chem. 2008 Apr 25;283(17):11155-63. doi: 10.1074/jbc.M710038200. Epub 2008 Mar 4. J Biol Chem. 2008. PMID: 18319253 Free article.

5

Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Sp1 in breast cancer cells.

Chuang CW, Pan MR, Hou MF, Hung WC. Chuang CW, et al. Among authors: hou mf. J Cell Physiol. 2013 Feb;228(2):341-8. doi: 10.1002/jcp.24136. J Cell Physiol. 2013. PMID: 22718198

6

Distant metastasis in triple-negative breast cancer.

Tseng LM, Hsu NC, Chen SC, Lu YS, Lin CH, Chang DY, Li H, Lin YC, Chang HK, Chao TC, Ouyang F, Hou MF. Tseng LM, et al. Among authors: hou mf. Neoplasma. 2013;60(3):290-4. doi: 10.4149/neo_2013_038. Neoplasma. 2013. PMID: 23373998

7

miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis.

Hsieh TH, Hsu CY, Tsai CF, Long CY, Chai CY, Hou MF, Lee JN, Wu DC, Wang SC, Tsai EM. Hsieh TH, et al. Among authors: hou mf. Oncotarget. 2015 Jan 1;6(1):494-509. doi: 10.18632/oncotarget.2674. Oncotarget. 2015. PMID: 25504437 Free PMC article.

8

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer.

Yin HL, Wu CC, Lin CH, Chai CY, Hou MF, Chang SJ, Tsai HP, Hung WC, Pan MR, Luo CW. Yin HL, et al. Among authors: hou mf. Int J Mol Sci. 2016 Aug 31;17(9):1432. doi: 10.3390/ijms17091432. Int J Mol Sci. 2016. PMID: 27589736 Free PMC article.

9

The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.

Hou MF, Luo CW, Chang TM, Hung WC, Chen TY, Tsai YL, Chai CY, Pan MR. Hou MF, et al. Exp Cell Res. 2017 Oct 15;359(2):458-465. doi: 10.1016/j.yexcr.2017.08.029. Epub 2017 Aug 24. Exp Cell Res. 2017. PMID: 28842166

10

CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.

Luo CW, Wu CC, Chang SJ, Chang TM, Chen TY, Chai CY, Chang CL, Hou MF, Pan MR. Luo CW, et al. Among authors: hou mf. Exp Cell Res. 2018 Feb 1;363(1):65-72. doi: 10.1016/j.yexcr.2017.12.032. Epub 2018 Jan 3. Exp Cell Res. 2018. PMID: 29305962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

415 results

Search Page